Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues

JS Reyat, A di Maio, B Grygielska, J Pike… - Frontiers in …, 2023 - frontiersin.org
Introduction Recent advances in human cardiac 3D approaches have yielded progressively
more complex and physiologically relevant culture systems. However, their application in the …

Multicellular 3D models for the study of cardiac fibrosis

V Picchio, E Floris, Y Derevyanchuk… - International Journal of …, 2022 - mdpi.com
Ex vivo modelling systems for cardiovascular research are becoming increasingly important
in reducing lab animal use and boosting personalized medicine approaches. Integrating …

Modelling cardiac fibrosis using three-dimensional cardiac microtissues derived from human embryonic stem cells

MO Lee, KB Jung, SJ Jo, SA Hyun, KS Moon… - Journal of biological …, 2019 - Springer
Background Cardiac fibrosis is the most common pathway of many cardiac diseases. To
date, there has been no suitable in vitro cardiac fibrosis model that could sufficiently mimic …

Three-dimensional cardiac microtissues composed of cardiomyocytes and endothelial cells co-differentiated from human pluripotent stem cells

E Giacomelli, M Bellin, L Sala, BJ Van Meer… - …, 2017 - journals.biologists.com
Cardiomyocytes and endothelial cells in the heart are in close proximity and in constant
dialogue. Endothelium regulates the size of the heart, supplies oxygen to the myocardium …

Activated cardiac fibroblasts control contraction of human fibrotic cardiac microtissues by a β-adrenoreceptor-dependent mechanism

P Błyszczuk, C Zuppinger, A Costa, D Nurzynska… - Cells, 2020 - mdpi.com
Cardiac fibrosis represents a serious clinical problem. Development of novel treatment
strategies is currently restricted by the lack of the relevant experimental models in a human …

In vitro Assays and Imaging Methods for Drug Discovery for Cardiac Fibrosis

G Palano, A Foinquinos, E Müllers - Frontiers in Physiology, 2021 - frontiersin.org
As a result of stress, injury, or aging, cardiac fibrosis is characterized by excessive
deposition of extracellular matrix (ECM) components resulting in pathological remodeling …

Generation of quiescent cardiac fibroblasts from human induced pluripotent stem cells for in vitro modeling of cardiac fibrosis

H Zhang, L Tian, M Shen, C Tu, H Wu, M Gu… - Circulation …, 2019 - Am Heart Assoc
Rationale: Activated fibroblasts are the major cell type that secretes excessive extracellular
matrix in response to injury, contributing to pathological fibrosis and leading to organ failure …

Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells

I Fernandes, S Funakoshi, H Hamidzada… - Nature …, 2023 - nature.com
Cardiac fibroblasts play an essential role in the development of the heart and are implicated
in disease progression in the context of fibrosis and regeneration. Here, we establish a …

Challenges and opportunities for the next generation of cardiovascular tissue engineering

S Cho, DE Discher, KW Leong, G Vunjak-Novakovic… - Nature …, 2022 - nature.com
Engineered cardiac tissues derived from human induced pluripotent stem cells offer unique
opportunities for patient-specific disease modeling, drug discovery and cardiac repair. Since …

Engineered human cardiac microtissues: The state-of-the-(he) art

K Soon, O Mourad, SS Nunes - Stem Cells, 2021 - academic.oup.com
Due to the integration of recent advances in stem cell biology, materials science, and
engineering, the field of cardiac tissue engineering has been rapidly progressing toward …